English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Krystal Biotech
Pacient Daily
| May 22, 2023
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
Patient Daily
| Apr 26, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily
| Apr 24, 2023
Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest
Trending
+
Pharmaceuticals
Patient Daily
| May 28, 2025
University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
+
Pharmaceuticals
Patient Daily
| May 29, 2025
Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+
Pharmaceuticals
Patient Daily
| Jun 2, 2025
PathAI collaborates with Northwestern Medicine on digital pathology advancements
+
Pharmaceuticals
Patient Daily
| May 27, 2025
New study shows effectiveness of recent RSV prevention strategies
